Loss of heterozygosity (LOH) of tumour-suppressor genes (for example, VHL, PTEN, NF1 or BRCA1) can lead to the induction of premature senescence programmes6, 28, 29, 30. The gene discussed is BRCA1; the disease is neoplasm.